# Artiva Biotherapeutics, Inc.: Form SCHEDULE 13D/A, filed May 28, 2026

- Company: [Artiva Biotherapeutics, Inc.](/companies/artv.md) (CIK 1817241)
- Form: SCHEDULE 13D/A
- Filed: 2026-05-28
- Accepted by EDGAR: May 28, 2026, 16:38 ET
- Period: not reported
- Accession: 0001931382-26-000009
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1817241/000193138226000009/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817241/000193138226000009/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817241/000193138226000009/xslSCHEDULE_13D_X02/primary_doc.xml

Filed May 28, 2026.
Source: SEC EDGAR, the filing index for accession 0001931382-26-000009. Last ingested by Listed: Nov 10, 2026, 01:58 ET. No prices; not investment advice.
